Can metallothionein be a useful molecular marker for selecting hepatocellular carcinoma patients for platinum-based chemotherapy?
Doki
Yuichiro
Y
Monden
Morito
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000096:biosynthesis; D006528:Carcinoma, Hepatocellular / Q000737:chemistry* / Q000188:drug therapy* / Q000378:metabolism; D002945:Cisplatin / Q000627:therapeutic use*; D006801:Humans; D008113:Liver Neoplasms / Q000737:chemistry* / Q000188:drug therapy* / Q000378:metabolism; D008668:Metallothionein / Q000032:analysis* / Q000096:biosynthesis; D018579:Patient Selection
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D008668:Metallothionein; D002945:Cisplatin